Quali sono gli orari di apertura?

Lunedì 09:00 - 18:00 Martedì 09:00 - 18:00 Mercoledì 09:00 - 18:00 Giovedì 09:00 - 18:00 Venerdì 09:00 - 18:00

Resono Ophthalmic Srl

Home
Italia
Sandrigo, Veneto
Resono Ophthalmic Srl

Sito Web Contatta l'azienda

Resono Ophthalmic is an innovative Italian SME founded in 2014 to develop and sell cutting-edge therapeutic devices for Ophthalmology.

Resono Ophthalmic is an Italian company developing therapeutical devices for Ophthalmology based on QMR®, a patented technology that stimulates the natural regeneration of cells. The key feature of our devices is the Quantum Molecular Resonance (QMR®) treatment. It is a patented technology that stimulates the natural regeneration of cells and tissue by delivering low-power, high-frequency electrical fields. We first applied this technique to treat Dry Eye Disease (DED) with Rexon-Eye®, a patented CE-marked medical device. Clinical trials in Italy and abroad have provided scientific evidence that Rexon-Eye® is a safe, effective, and long-term treatment option for all types of DED. The benefits of QMR® in stimulating cell and tissue regeneration are currently under investigation also for its possible application in other eye diseases. For more information about technical and clinical details, please visit our website.

*QMR® is a registered trademark by Telea Electronic Engineering.

23/10/2026

At ESCRS 2026, Prof. José María Martínez de la Casa presented promising clinical findings on QMR Technology in glaucoma patients with dry eye, including improvements in tear film stability and reduced artificial tear use.

📚 Interested in the research? Discover more through the link in our bio.

20/10/2026

Can QMR Technology make a difference for glaucoma patients with Dry Eye Disease?

Prof. José María Martínez de la Casa shares his clinical experience and the improvements observed in patients with glaucoma and dry eye following Rexon-Eye treatment.
Watch the full presentation on YouTube Channel.

19/10/2026

🇫🇷 Deux webinaires pour explorer de nouvelles perspectives dans la prise en charge de la sécheresse oculaire !

Organisés par Ophtalmic Compagnie, ces deux rendez-vous réuniront le dr. Cati Albou-Ganem et le Dr Docteur Romain Mouchel pour explorer les applications de la technologie QMR et de Rexon-Eye dans les pathologies de la surface oculaire, la douleur cornéenne et la prise en charge pré et post-opératoire.

🔗 Réservez votre place dès maintenant ! Lien en bio.

16/10/2026

QMR Technology takes a non-thermal approach to tissue interaction, opening new perspectives for ocular surface management.

With Rexon-Eye, this technology becomes part of clinical practice through a non-invasive, patient-friendly treatment approach.

Curious about the science behind QMR? Explore its biological mechanisms and published clinical studies through the link in our bio.

14/10/2026

How can QMR Technology be integrated into a refractive and cataract practice?

Dr. Roger Zaldivar shares his clinical experience with Rexon-Eye as part of his ocular surface protocols, from pre-operative preparation to post-operative management, including his experience with neurotrophic patients.

Want to learn more about the protocols and scientific evidence?

Contact us or your local Rexon-Eye distributor.

06/10/2026

A new chapter for QMR Technology.

For the first time, we brought QMR research in the retinal field to , sharing the scientific work and ongoing research exploring its potential beyond the ocular surface.
A special thank you to Prof. Luigi Donato for presenting his latest research around QMR and the retina.

Contact us to explore the science behind the technology.

02/10/2026

Join us on Saturday, 3 October at 10:30, to discover the latest research on QMR® Technology in the retinal field.

An opportunity to learn more about the ongoing research and discuss your questions directly with Prof. Donato.
📍 Booth F13
🗓 Saturday, 3 October
🕙 10:30

We look forward to seeing you there!

30/09/2026

A new generation of Dry Eye patients?
Content creators, influencers and highly screen-exposed professionals are becoming an increasingly relevant patient profile.

Dr. .benatti shares a dedicated approach developed with our team, integrating Rexon-Eye into their Dry Eye management.

15/09/2026

2026: Expectations vs. Reality
Resono Team Edition

A few intense days, countless meetings, great conversations… and definitely some unexpected moments along the way.
Tired? Yes. Worth it? Absolutely.
Thank you, ESCRS 2026! See you next year!

13/09/2026

All around the world we’re getting every time the provemebtnof the versatility of the QMR and its applications. From the regeneration of the nerves and neuropathic corneal pain to the treatment of the AMD . All thanks to these incredible experts who help us to discover the whole potential of this unique technology

Indirizzo

Sandrigo

Orario di apertura

Lunedì	09:00 - 18:00
Martedì	09:00 - 18:00
Mercoledì	09:00 - 18:00
Giovedì	09:00 - 18:00
Venerdì	09:00 - 18:00

Sito Web

https://rexoneye.com/

Notifiche

Lascia la tua email e sarai tra i primi a sapere quando Resono Ophthalmic Srl pubblica novità e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.